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MARSH, J. T., G. SCHUBARTH, W. S. BROWN, W. RIEGE, R. STRANDBURG, D. DORSEY, A. MALTESE AND D. KUHL.
PETand P300relationshipsin earlyAlzheimer'sdisease. NEUROBIOL AGING 11(4) 471--476, 1990.--The P300 (P3) wave of the
auditory brain event-related potential was investigated in patients with probable Alzheimer's disease to determine whether P300 latency
discriminated these patients from controls and whether prolonged P300 latency correlated with rates of brain glucose metabolism as
measured by Positron Emission Tomography. P300 latency was prolonged by more than 1.5 standard deviations from age expectancy
in 14 of 18 patients, but none of 17 controls. In these subjects P300 latency was shown to be inversely correlated with relative
metabolic rates of parietal and, to a lesser extent, temporal and frontal association areas, but not with subcortical areas.
Alzheimer's disease

Event-related potentials

P300

THE latency of the P300 (or P3) component of the brain
event-related potential (ERP) has been demonstrated to increase
with aging in normal adults (2, 4, 13, 34, 38, 41). A number of
studies have also shown P300 latency to be significantly prolonged
in dementia of varying etiology. Depending on the study, from 50
to 80% of demented patients have P300 latencies prolonged more
than 2 standard deviations beyond that which would be predicted
by the linear regression of P300 on the age of nondemented adults
(3, 12, 14, 17-19, 48). Further, P300 latency has been shown to
track changes in mental status in patients whose confusional state
or dementing illness varied in severity over time, increasing as
dementia worsens and decreasing with remission (16). However,
some investigators have questioned whether this measure is
sufficiently sensitive to hold any promise for clinical diagnostic
utility (35).
P300 latency is a measure of cognitive processing time (8, 30,
47) and increases with task difficulty (5, 10, 15, 27, 44, 45).
However, the neural substrates of abnormal P300 latency are
unknown. For example, in patients with probable Alzheimer's
disease, it is not known whether or not the abnormally prolonged

Positron Emission Tomography

P300 latency in the majority of these patients is associated with
functional deficits in specific brain regions. The opportunity to
address this question arose when brain event-related potentials
were obtained from patients with early probable Alzheimer's
disease who were participating in a larger study to determine PET
markers of probable Alzheimer's disease (pAD). Glucose utilization indexed by the uptake of (F-18) 2-fluoro-2-deoxy-glucose has
been shown to be sensitive to focal changes in brain function
associated with degenerative diseases of the nervous system (28,
37, 42).
This report demonstrates not only the sensitivity of P300
latency to early stages of pAD, but also a strong relationship
between P300 latency and metabolic rate of parietal, frontal, and
temporal cortical regions which are reduced in varying degrees in
pAD (7, 11, 29, 43).
METHOD
Eighteen individuals with early probable Alzheimer's disease
were compared with 17 age-matched healthy, nondemented individuals in this study, pAD subjects were selected from a much

larger group of over 300 individuals referred from the community
on the basis of criteria characteristic of possible early Alzheimer's
disease. Patients were included in the study if they met the
following criteria: between 50 and 75 years of age, gradual and
progressive loss of memory and cognitive function with inconspicuous onset, normal consciousness, and impairment in 3 of 5
cognitive functions (orientation, judgement and problem solving,
social functioning, home and hobbies, personal care). Patients and
controls were excluded from the study if there was evidence of any
other neurological disorder. Information for diagnosis and inclusion in this study was obtained using a three-stage diagnostic
process: 1) Preliminary Evaluation: Extended interview of subject
and family members regarding education and occupational background, and medical and neurological history. Administration of
several scales and tests including the Mini-Mental State, WAIS
Digit Span, Word Generation, Zung Depression Scale, Blessed
Dementia Scale, and Hachinski Scale. 2) Psychiatric, Neuropsychological and Neurolinguistic Evaluation: Psychiatric interview;
neuropsychological evaluation of memory, intelligence, problem
solving, abstraction and spatial relations; neurolinguistic evaluation of comprehension, expression, word knowledge, and writing;
and completion of a Clinical Dementia Rating (23) based on all the
above data. 3) Laboratory Tests and Complete Neurological
Exam: Neurological examination including mental status, systems
review, and vital signs; review of laboratory measures; and
completion of second Hachinski Scale and Clinical Dementia
Rating based on these data.
Diagnosis of pAD was confirmed on the basis of subsequent
annual follow-up examinations for up to 4 years after the initial
study. These diagnostic tests served to establish the presence and
severity of dementia, and to rule out diagnoses other than
Alzheimer's disease. Out of an initial group of 32 patients
originally diagnosed as questionable AD, the 18 subjects of
this study were confirmed to be probable AD at follow-up 1 to 2
years later. Basis for post hoc elimination from this study was
evidence of pseudodementia, atypical course, and indications of
multiple infarct. Twelve of the 18 pAD patients and all 17 controls
were also included in a longitudinal study of P300 latency in
dementia (1).
Under the criteria of the Clinical Dementia Rating, 9 patients
were given a rating of CDR 0.5 (questionable dementia) and 9
patients a CDR of 1.0 (mild dementia) at the time of original
examination. Patients in this study had a mean age of 65.2---5.8
years (standard deviation) and a mean Mini-Mental State [MMS;
(8)] score of 24.7 ± 1.3. The 17 age-matched control persons had
a mean age of 64.4__.6.7 and a mean MMS of 29.6±0.7.
Each patient and control underwent PET scans of cerebral
glucose utilization involving the injection of (F-18)-labeled 2fluoro-2-deoxy-glucose (FDG) (37). Local cerebral metabolic
utilization of glucose was measured following Sokoloff's model
(46). This study utilized a third generation tomograph (NeuroEcat,
CTI Inc., Knoxville, TN), which has image resolution of 9.5 mm
in the plane of section and 12.4 mm in the axial direction. Subjects
remained in the resting state (eyes and ears open) on the gurney of
the tomograph after injection of 5-10 mCi FDG intravenously.
Arteriolized blood was sampled and, after 40 min, multiple scans
were taken at 0 degrees to the orbital-meatal lines and were
completed after an accumulation of 2-3 million counts per image.
Image values were converted to regional cerebral metabolic rate of
glucose utilization (rCMRGlu) based on the model of Phelps and
Huang using constants derived from young adults (36). These
rCMRGlu (in micromoles/min/100 grams) did not significantly
differ from those of a group of old persons (20). If the rCMRGlu
is a measure of the function of a specific region, then the
cross-sectional image of the brain FDG metabolism presents a
functional map of brain activity in regions of interest.

Based on hypotheses concerning possible neural systems which
might modulate P300 latency (parahippocampal region), together
with evidence regarding decreased function of temporal, parietal
and to a lesser extent frontal cortex in moderately demented
Alzheimer's patients (11, 42, 43), we selected posterior parietal,
temporal, parahippocampal and frontal PET measures reconstructed from multiple scans in the horizontal plane. Relationships
between P300 latency and subcortical function were investigated
using a mean of PET values from the caudate and thalamus regions
(caudate-thalamus). In order to control for individual differences
in overall brain metabolic rate and more specifically observe
distributions of neural activity, PET measures from areas of
interest were expressed as a ratio of regional to cerebellar
metabolic rate. Cerebellar metabolism is known to be little
affected in the early stages of Alzheimer's type dementia (25).
For P300 recording, individuals listened to a series of moderate
intensity, low pitched tones (250 Hz, 70 dB SPL, 55 msec in
duration, 1.5 sec ISI) occasionally and randomly replaced by a
higher pitched, louder tone (450 Hz, 84 dB, occurring on 20% of
trials). Subjects were asked to keep a cumulative count of the
target tones (32 in all).
ERPs were recorded from midline parietal (Pz), central (Cz)
and frontal (Fz) scalp positions referenced to the left ear, the right
ear serving as ground. EEG was amplified with gain of 14,140 and
filtered at 0.1 to 50 Hz (3 dB down). Responses were digitized for
computer averaging at 250 samples per second. ERPs were
averaged over a one-second epoch, including 100 msec of prestimulus baseline and 900 msec of ERP. Automatic artifact
rejection of single trial responses was accomplished via an
amplitude window set independently for each subject. Amplitude
criteria were set to reject large voltage deflections such as
eye-movement and eye-blink artifact apparent in simultaneous
EEG records.
The P300 wave was identified as the largest positive wave 280
msec or longer stimulus onset, present in responses to the target
(counted) stimuli and absent (or considerably attenuated) in
responses to the frequent (noncounted) stimuli. P300 latency was
measured at Pz, using the other electrodes to help identify the
P300 wave. Latency was measured from the midpoint of a
horizontal line drawn between the rise and fall of the wave at
approximately the 2/3 amplitude level. Since P300 latency increases in a systematic way with age, latency was expressed in
standard deviation units (Z-scores) from the P300 latency/age
regression line calculated from a group of 57 normal individuals
over the age of 50 previously run in our laboratory using the same
stimulus and recording parameters (4). The regression formula
used to calculate the expected normal P300 latency in milliseconds
was:
expected = (age x 2.05) + 199
Z-scores were calculated using the following formula:
Z = (actual - expected)/25.3
Statistical analysis of the data utilized t-tests, Pearson correlation, multiple regression and stepwise discriminant function analysis as appropriate. To calculate the .01 significance level adjusted
for the number of correlations performed (shown as the dashed line
in Fig. 3), a critical r-value was obtained by dividing the
significance level of .01 by the number of comparisons. This
yielded a normalized probability density value. To make this a
two-tailed test of significance, that value was halved and the
corresponding t-value obtained. The t-value was converted into a
critical r-value using a formula given on p. 661 of (21).
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FIG. 1. Cross-subject mean ERPs based on a P300 latency median split of subjects in each group: Controls with P300 latency less than (N = 9), and greater
than (N = 8), 340 msec; pAD subjects with latencies less than (N = 9) and greater than (N = 9) 400 msec. Responses to the frequent (dashed) and target
(solid) stimuli are superimposed for each of 3 electrode locations (Pz, Cz, Fz). The P300 (labeled as "P3") is evident as the positivity (upward deflection)
beginning approximately 250 msec after the tone onset (vertical marker on the time scale). Since amplitude for each subject was normalized before creating
these cross-subject averages, amplitude differences between groups are not represented. However, frequent/rare amplitude relations and scalp topography
(Pz, Cz, Fz) are preserved. Normalization of amplitude for this figure was done to allow equal contribution of each subject to the cross-subject mean
waveforms and, thus, more precise representation of the mean latency of components. Time scale tick-marks occur every 100 msec.

RESULTS
Figure 1 presents examples of ERPs from 2 normal and 2
demented individuals, illustrating longer latencies for the pAD
subjects. P300 latencies in standard deviation units (Z-scores) for
all normal ( C D R = 0 ) and pAD patients (CDR 0.5 and 1.0) are
presented in Fig. 2. The P300 latency of all 17 normal subjects fell
within _ 1.5 standard deviations of our P300 latency/age regression line. However, 14 of 18 pAD patients had P300 latencies
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FIG. 2. P3 latency data converted to Z-scores for all subjects. From the
left, columns are 17 normal controls (CDR = 0.0), 9 questionable dementia
(CDR=0.5), and 9 mild dementia (CDR= 1.0) AD patients. The dashed
line represents the maximum Z-score value for the normal controls of this
study. Only four of 18 patients fall within the range of normal subjects.

beyond the range of P300 latencies (in Z-scores) for the normal
group. There was a highly significant difference between normal
and pAD subjects in both mean P300 latency Z-score ( t = 4 . 8 6 ,
p < 0 . 0 0 0 1 ; normal m e a n = - 0 . 0 8 ; pAD m e a n = 3 . 3 7 ) and in
actual P300 latency ( t = 4 . 9 5 , p < 0 . 0 0 0 1 ; normal m e a n = 3 3 5
msec; pAD m e a n = 4 3 1 msec).
In order to test the ability of P300 latency to distinguish
between early AD patients and normal controls, a stepwise
discriminant function analysis was performed with P300 latency
Z-score and PET ratio values as variables. The first variable
entered was P300 latency Z-score, which yielded a 89% correct
classification with no controls classified as AD, and four AD
misclassified as controls. When the Parietal/Cerebellum metabolic
measure was added to the discriminant function, the correct
classification increased to 91.4% with one false positive, i.e., one
control classified as AD. This level of discrimination is notable in
view of the fact that the patients in this study were initially
classified (i.e., at time of P300 and PET measurement) as
questionable Alzheimer's disease, having symptomatology characteristic of the very early stages of dementia.
While the groups differed significantly in P3 latency, no
difference was seen for the earlier N1 and P2 components. N1
latencies for the pAD and control groups were 99.3 msec and 99.5
msec, respectively ( t = 0 . 0 6 , p = n s ) . P2 latencies were 177.3
msec and 182.2 msec ( t = 0 . 8 8 , p = n s ) .
Within the pAD group, P300 latency did not differ significantly
according to CDR grouping (CDR 0.5; mean Z - s c o r e = 3 . 1 2 ,
mean l a t e n c y = 4 2 0 msec; CDR 1.0; mean Z - s c o r e = 3 . 5 7 , mean
l a t e n c y - 4 4 0 msec). A relationship was found between P300
latency and scores on the Mini-Mental State Exam. For the
combined group of patients and normals, there was a significant
correlation between P300 latency and MMS scores (MMS vs.
P300 Z-score, r = - . 5 8 ,
p < 0 . 0 0 1 ; MMS vs. P300 latency,
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FIG. 3. Correlation of P3 latency (in Z-scores) with PET measures for the combined pAD
and control groups. From left to right, bars represent correlations with the following PET
measures: global metabolic rate; parietal metabolic rate divided by cerebellum metabolic
rate (Pt/Cb); temporal divided by cerebellum (Tmp/Cb); frontal divided by cerebellum
(Ft/Cb); parahippocampal divided by cerebellum (PHp/Cb); caudate-thalamus divided by
cerebellum (CTh/Cb); and frontal divided by parietal (Ft/Pt). All correlations are graphed
as absolute values. (As predicted, all correlations are negative with the exception of Ft/Pt,
which is positive.) The dashed line represents the two-tailed p<0.01 significance level,
adjusted for multiple comparisons, as described in the Method section.

r = - .61, p<0.001). However, within the pAD group itself, there
was not a significant correlation between P300 Z-score and MMS.
Thus, while P300 latency was indicative of the presence of pAD,
even in the early mild phases, it was not consistently related to the
degree of dementia as indexed either by CDR or MMS scores.
Correlations were calculated for the present data between the
P300 latency Z-score vs. PET measures for various cortical and
subcortical areas in the combined pAD and control group (Fig. 3).
P300 latency was not correlated with global metabolic rate or with
that of caudate-thalamic regions. However, significant correlations were observed in metabolic rates of cortical regions expressed as ratios of cerebellar metabolism. The parietal ratio
showed the most significant negative correlation ( r = - . 5 8 ,
p<0.001; see Fig. 4), i.e., lower FDG uptake was associated with
longer P300 latency. Progressively lower but significant negative
correlations were found with frontal and temporal ratios. When
combined into a multiple regression equation, PET measures
accounted for a significant amount of variance in P300 latency
Z-scores (Re=.501, F = 3 . 8 7 , p<0.0001). The variance explained was primarily attributable to the Parietal/Cerebellum
metabolic ratio (R 2= .335, F = 4 . 7 9 , p<0.037).
Because of the more rapid parietal, as compared to frontal,
decrement in cortical function in early Alzheimer's disease (11,29),
we anticipated a positive correlation between the P300 latency
Z-scores and a Frontal/Parietal PET ratio in these patients. This
correlation was not significant.
Relationships between PET ratios and P300 latency were also
tested within the pAD group alone. P300 latency Z-score was
correlated significantly with Frontal/Cerebellum metabolic ratio
(r = - .49, p<0.02), but not with those from other brain regions.

was observed in early stage AD patients and controls.
The high rate of correct classification in this study (89%) as
compared to others in the literature [(14), 80%; (3), 72%; (48),
83%; (17), 79%; (35), 31%] may in part reflect the extensive
selection procedures, including thorough screening for other
possible etiologies of cognitive decline. Also contributing to
successful discrimination was the strong association between P300
latency and the functional status of the cortical tissue most at risk
in early Alzheimer type dementia. Thus studies using mixed
groups or other types of dementia, e.g., multiinfarct, Parkinson's,
and Huntington's patients, have yielded lower discrimination
rates, perhaps due to less consistent involvement of cortical
association regions in these disorders.
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The results of this study demonstrate that
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frontal and temporal areas. It is noteworthy

.0

0.0
P3

P300 latency is one
cerebral association
to a lesser degree,
that this association

2.0
4.0
L,qTENCY [~

6.~3
8.0
Score)

10.0

FIG. 4. Scanerplot of the relationship between P3 Z-score and parietal
metabolic rate divided by cerebellum metabolic rate for normal controls
(solid diamonds) and pAD patients (open diamonds). The line represents
the regression function: Pt/Cb rate = 1.084 - (0.049 × P3 Z-score).

While P300 latency discriminated between early Alzheimer's
patients and controls, it does not differentiate between questionable and mild stages of dementia (Fig. 2; CDR 0.5 and CDR 1.0).
There is, however, evidence that P300 latency is sensitive to the
degree of dementia when a wider range of cognitive decline is
considered (4, 18, 31, 39). P300 latency, as a measure of
perceptual processing speed, represents only one facet of the many
cognitive abilities summarized in the CDR or MMS. While
various mental abilities are relatively well correlated over broad
functional ranges, within more narrowly defined groups, such as
CDR 0.5 and 1.0, these abilities may not be strongly associated.
An alternative hypothesis for the lack of association between P300
latency and CDR or MMS in pAD patients would propose that
P300 latency is more sensitive to individual differences in general
cognitive ability than either CDR or MMS within the early stages
of AD.
The strong association of P300 latency with the functional
status of parietal association cortex is consistent with what is
known about both the cognitive processes related to P300 latency
(i.e., perceptual recognition time), and those cognitive processes
which depend heavily on the participation of the parietal cortical
region (i.e., perceptual discrimination and recognition). Considerable evidence supports the notion that P300 latency is prolonged
by increasing task difficulty in such a way as to require greater
depth of stimulus processing (5, 8, 10, 15, 27, 30, 44, 45, 47).
Since the importance of parietal cortex, particularly in the temporal-parietal-occipital (TPO) region, in information processing is
well established (6, 22, 26, 32, 33), the sensitivity of P300 latency
to compromised functioning of this region is not surprising.
Evidence is also accumulating linking P300 to some aspects of
memory function (24, 40, 49). For example, Polich et al. (40)
have reported an association between P300 latency and immediate
memory of numbers in the Digit Span test in normal individuals.
Significant correlations were found in the subjects of our study
between P300 latency and a number of neuropsychological tests of
memory function. Thus, prolonged P300 latency and decreased

function in the TPO area may be associated with memory decline.
Impaired memory is one of the earliest and most prominent
features of Alzheimer type dementia.
It should be emphasized that these data do not bear on the issue
of the neural generators of the P300 wave. Rather, they reveal
aspects of the neural systems required for the rapid and efficient
information processing reflected in a short latency P300. Efficient
processing in parietal cortex would, thus, be a necessary contributor to the elicitation of a normal latency P300, which itself may
be generated in other neural tissue.
The dependence of P300 latency on the level of parietal lobe
functioning suggested in these data must be considered in the light
of abnormally prolonged P300 latencies in patients with primarily
subcortical neurological disorders, i.e., Parkinson's disease and
Huntington's disease (18,19). In the case of these subcortical
dementias, latencies of earlier components, particularly N1 and
P2, are also delayed along with the P300. In Alzheimer's patients
these early waves have normal latencies and the later P300 is
specifically delayed (12). As indicated in the results, this was also
the case for the pAD patients in this study. Thus, while delayed
P300 latency in subcortical dementia might be characterized as a
"downstream" effect of changes in earlier stages of processing, in
Alzheimer's dementia P300 latency appears to be a more specific
reflection of the integrity of the parietal cortex.
Finally, we believe that these results bear on the possible
clinical utility of a P300 latency measure. Our results suggest that
P300 latency can be used as a one-directional clinical test in which
normal latency cannot be said to rule out the presence of
dementing illness, but prolonged latency would suggest a high
probability of dementia. Although the relationship should be tested
in other dementias, prolonged P300 latency, together with normal
latency of earlier components, appears to be an index of the
declining functional status of cortical association tissue, particularly of the parietal lobe. Increase in P300 latency would thus be
a reflection of the compromised status of a specific brain system,
rather than type of dementing disease.
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